BioFilm Control Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
14
- Latest Deal Type
-
Liquidation
BioFilm Control General Information
Description
Operator of a biotechnology company intended to detect the biofilm behavior of microorganisms. The company's technology includes innovative services for in vitro diagnostics tests and offers studies to detect the susceptibility of bacteria to antibiotics, both in planktonic and biofilm populations, enabling clients to operate with advanced biotechnical methods and help them characterize and optimize the activity of their products on micro-organisms.
Contact Information
Website
www.biofilmcontrol.comCorporate Office
- 5 Rue Emile Duclaux
- Biopôle Clermont-Limagne
- 63360 Saint-Beauzire
- France
Corporate Office
- 5 Rue Emile Duclaux
- Biopôle Clermont-Limagne
- 63360 Saint-Beauzire
- France
BioFilm Control Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Bankruptcy: Liquidation | 07-Dec-2023 | 00.000 | Completed | Bankruptcy: Liquidation | ||
6. Secondary Transaction - Private | 00.000 | Completed | Generating Revenue | |||
5. Later Stage VC | 19-Jul-2018 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
4. Later Stage VC | 01-Dec-2014 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
3. Later Stage VC | 01-Oct-2012 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
2. Angel (individual) | 19-Nov-2010 | $1.48M | $1.48M | 00.000 | Completed | Startup |
1. Accelerator/Incubator | Completed | Startup |
BioFilm Control Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
A shares | 000 | 0000.000000 | 00000.00 | 00000.00 | 00 | 00000.00 | 00.000 | |
A shares | 0,000 | 0000.000000 | 00000.00 | 00000.00 | 00 | 00000.00 | 00.00 | |
B Shares | 00 | 0000.000000 | 00000.00 | 00000.00 | 00 | 00000.00 | 0.000 | |
Ordinary | 1,637 | $583.157932 | $1046.89 | $1046.89 | 1x | $1046.89 | 21.13% | |
B Shares | 823 | $583.157932 | $1512.71 | $1512.71 | 1x | $1512.71 | 10.62% |
BioFilm Control Patents
BioFilm Control Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3888094-A1 | Method for detecting and monitoring the formation of biofilms | Inactive | 30-Nov-2018 | 00000000 | |
US-20220017937-A1 | Method for detecting and monitoring the formation of biofilms | Pending | 30-Nov-2018 | 00000000 | |
EP-3697414-A1 | Use of cloxacillin to inhibit/prevent biofilm formation | Inactive | 18-Oct-2017 | 0000000000 | |
FR-3072279-B1 | Use of cloxacillin to inhibit / prevent the formation of biofilm | Inactive | 18-Oct-2017 | 0000000000 | |
CA-3079023-A1 | Use of cloxacillin to inhibit/prevent biofilm formation | Pending | 18-Oct-2017 | A61K31/431 |
BioFilm Control Signals
BioFilm Control FAQs
-
When was BioFilm Control founded?
BioFilm Control was founded in 2004.
-
Who is the founder of BioFilm Control?
Nicolas Bara and Thierry Bernardi are the founders of BioFilm Control.
-
Where is BioFilm Control headquartered?
BioFilm Control is headquartered in Saint-Beauzire, France.
-
What is the size of BioFilm Control?
BioFilm Control has 14 total employees.
-
What industry is BioFilm Control in?
BioFilm Control’s primary industry is Biotechnology.
-
Is BioFilm Control a private or public company?
BioFilm Control is a Private company.
-
What is BioFilm Control’s current revenue?
The current revenue for BioFilm Control is 000000.
-
How much funding has BioFilm Control raised over time?
BioFilm Control has raised $7.79M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »